Sialic Acids, Part II: Biological and Biomedical Aspects, Vol 76. Advances in Carbohydrate Chemistry and Biochemistry

  • ID: 4622067
  • Book
  • 193 Pages
  • Elsevier Science and Technology
1 of 4

Sialic Acids, Volume 76, the most recent release in the Advances in Carbohydrate Chemistry and Biochemistry series, is the second volume of a two-volume set devoted to the sialic acids. Vol. 76, devoted to the biological and biomedical aspects of sialic acids, includes chapters on "Sialic Acids in Neurology," "Sialic Acids in Nonenveloped Virus Infections," and "The Biology of Gangliosides," all written by leading experts in their fields.

  • Features contributions from leading authorities and industry experts who specialize in carbohydrate chemistry, biochemistry and research
  • Integrates the industrial, analytical and technological aspects of biochemistry, organic chemistry and instrumentation methodology in the study of carbohydrates
  • Informs and updates on all the latest developments in the field

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 4
1. Sialic Acids in Neurology Chihiro Sato and Ken Kitajima 2. Sialic Acids in Nonenveloped Virus Infections Bärbel S. Blaum and Thilo Stehle 3. The Biology of Gangliosides Ronald L. Schnaar
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Baker, David C.
Prof. David C. Baker has a broad research and teaching experience in the organic and medicinal chemistry of the carbohydrates, including nucleosides and cell-surface carbohydrates that are documented in over 200 publications, presentations, and patents. He was elected a Fellow of the American Chemical Society where he has been active principally in the Division of Carbohydrate Chemistry.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4622067
Adroll
adroll